LN-030

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameLN-030
Drug Alias Nameautologous cell vaccine (LipoNova)LN-030
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLipoNova AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLipoNova AG
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A